MOG and Alzheimer disease: In recent years, mounting studies have shown that anti-NMDAR and MOG antibodies can be detected simultaneously or successively in the same patient, and their coexistence could lead to the overlapping or variation of clinical manifestations and simultaneous or sequential emergence of the clinical phenotypes of MOG-AD and anti-NMDAR encephalitis overlapping syndrome (MNOS) (4–7).